New shot shows promise against tough skin cancer
NCT ID NCT07280832
First seen Jan 11, 2026 · Last updated May 21, 2026 · Updated 17 times
Summary
This study tests a new drug called JMT108 in people with advanced melanoma that cannot be removed by surgery or has spread. The goal is to see if the drug is safe and can shrink tumors. About 188 adults who have tried other treatments or have no options left will take part. This is an early-stage trial, so the main focus is safety and finding the right dose.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UNRESECTABLE LOCALLY ADVANCED OR METASTATIC MELANOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
BeiJing Cancer Hospital EC
RECRUITINGBeijing, Beijing Municipality, China
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.